Detalhe da pesquisa
1.
Histological diagnostic discrepancy and its clinical impact in bone and soft tissue tumors referred to a sarcoma center.
Cancer Sci
; 2024 May 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38763523
2.
Inflammatory Rhabdomyoblastic Tumor: Clinicopathologic and Molecular Analysis of 13 Cases.
Mod Pathol
; 37(1): 100359, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37871654
3.
What Are the Complication Rates and Factors Associated With Total Femur Replacement After Tumor Resection? Findings From the Japanese Musculoskeletal Oncology Group.
Clin Orthop Relat Res
; 482(4): 702-712, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37796200
4.
IDH-negative chondrosarcoma with metachronous dedifferentiation only in the metastatic site-A diagnostic pitfall.
Genes Chromosomes Cancer
; 62(12): 755-760, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37732625
5.
Frequent CD30 Expression in an Emerging Group of Mesenchymal Tumors With NTRK, BRAF, RAF1, or RET Fusions.
Mod Pathol
; 36(4): 100083, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36788089
6.
Protocol for the 2ND-STEP study, Japan Clinical Oncology Group study JCOG1802: a randomized phase II trial of second-line treatment for advanced soft tissue sarcoma comparing trabectedin, eribulin and pazopanib.
BMC Cancer
; 23(1): 219, 2023 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36890471
7.
Protocol for a confirmatory trial of the effectiveness and safety of palliative arterial embolization for painful bone metastases.
BMC Cancer
; 23(1): 109, 2023 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-36721103
8.
Safety and efficacy of multiple tyrosine kinase inhibitors in pediatric/adolescent and young adult patients with relapsed or refractory osteosarcomas: A single-institution retrospective analysis.
Pediatr Blood Cancer
; 70(7): e30360, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37073613
9.
Clinical characteristics of primary cutaneous and subcutaneous Ewing sarcoma.
Jpn J Clin Oncol
; 53(7): 604-610, 2023 Jun 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37093679
10.
Predictive value of peripheral blood markers in soft tissue sarcoma patients treated with eribulin.
Jpn J Clin Oncol
; 53(6): 494-500, 2023 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36989466
11.
Soft-tissue sarcoma with MN1-BEND2 fusion: A case report and comparison with astroblastoma.
Genes Chromosomes Cancer
; 61(7): 427-431, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35094441
12.
Preoperative Denosumab Therapy Against Giant Cell Tumor of Bone is Associated with an Increased Risk of Local Recurrence After Curettage Surgery.
Ann Surg Oncol
; 29(6): 3992-4000, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35175454
13.
Poor Treatment Outcomes with Second-Line Chemotherapy in Advanced Synovial Sarcoma.
Oncology
; 100(7): 370-375, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35405680
14.
Safety and effectiveness of eribulin in Japanese patients with soft tissue sarcoma including rare subtypes: a post-marketing observational study.
BMC Cancer
; 22(1): 528, 2022 May 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35546669
15.
Dedifferentiation in low-grade osteosarcoma: a Japanese Musculoskeletal Oncology Group (JMOG) study.
Int J Clin Oncol
; 27(11): 1758-1766, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35932377
16.
Prognostic impact of IDH mutations in chondrosarcoma.
J Orthop Sci
; 27(6): 1315-1322, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34531086
17.
Image-guided core needle biopsy for musculoskeletal lesions.
J Orthop Sci
; 27(2): 448-455, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33531215
18.
Phase II clinical trial of pazopanib for patients with unresectable or metastatic malignant peripheral nerve sheath tumors.
Int J Cancer
; 148(1): 140-149, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32638374
19.
Clinical Outcomes of Patients with Metastatic Solitary Fibrous Tumors: A Japanese Musculoskeletal Oncology Group (JMOG) Multiinstitutional Study.
Ann Surg Oncol
; 28(7): 3893-3901, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33146837
20.
Efficacy and safety of TAS-115, a novel oral multi-kinase inhibitor, in osteosarcoma: an expansion cohort of a phase I study.
Invest New Drugs
; 39(6): 1559-1567, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34117970